Cilostazol contraindications: Difference between revisions

Latest revision as of 22:23, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Cilostazol#Contraindications]]
-{{Cilostazol}}
-{{CMG}}; {{AE}} {{AZ}}
-==Contraindication==
-'''''Cilostazol (PLETAL) and several of its metabolites are inhibitors of [[phosphodiesterase]] III. Several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class III-IV [[congestive heart failure]]. PLETAL is contraindicated in patients with congestive heart failure of any severity.PLETAL is contraindicated in patients with haemostatic disorders or active pathologic bleeding, such as bleeding [[peptic ulcer]] and intracranial bleeding. PLETAL inhibits platelet aggregation in a reversible manner. PLETAL is contraindicated in patients with known or suspected [[hypersensitivity]] to any of its components<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PLETAL (CILOSTAZOL) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d75b58-bafb-4440-b8d7-4f4079c08b0b | publisher =  | date =  | accessdate =  }}</ref>'''''
-==References==
-{{Reflist}}
-[[Category:Cardiovascular Drugs]]
-[[Category:Drugs]]